Sanofi develops and markets drugs with a concentration in vaccines, immunology, oncology, cardiovascular disease, diabetes, and over-the-counter treatments... Show more
Industry PharmaceuticalsMajor
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JSEAX | 21.56 | -0.31 | -1.42% |
JPMorgan International Equity A | |||
GSMVX | 15.96 | -0.23 | -1.42% |
Goldman Sachs Small/Mid Cap Value Instl | |||
LCAGX | 15.35 | -0.23 | -1.48% |
Lord Abbett International Growth C | |||
HRLVX | 21.97 | -0.38 | -1.70% |
Harbor Large Cap Value Admin | |||
CCERX | 26.63 | -1.16 | -4.17% |
Columbia Large Cap Enhanced Core R |
A.I.dvisor tells us that SNYNF and NVSEF have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SNYNF and NVSEF's prices will move in lockstep.
Ticker / NAME | Correlation To SNYNF | 1D Price Change % | ||
---|---|---|---|---|
SNYNF | 100% | -2.04% | ||
NVSEF - SNYNF | 27% Poorly correlated | +1.00% | ||
BIIB - SNYNF | 21% Poorly correlated | -1.25% | ||
OGN - SNYNF | 17% Poorly correlated | -0.30% | ||
SCLX - SNYNF | 7% Poorly correlated | -7.13% | ||
MIRA - SNYNF | 4% Poorly correlated | -2.42% | ||
More |